ECARX Announces Completion of the Final Tranche of US$100 million Convertible Notes
LONDON, Feb. 10, 2026 /PRNewswire/ -- ECARX Holdings Inc. (Nasdaq: ECX) ("ECARX" or the "Company"), a global mobility tech provider, today announced that the aggregate US$100 million in convertible notes (the "2025 Notes") contemplated by the...
Nexdata Announces Completion and Full Operation of Its World-Class Embodied AI Data Collection Factory
SINGAPORE, Jan. 27, 2026 /PRNewswire/ -- As embodied AI rapidly evolves from foundation models and software-based agents toward real-world intelligent robots, the industry is facing a critical bottleneck: the large-scale availability of...
Sisram Medical Reports Completion of NIFDC Testing for DAXXIFY in China
Marking a Key Milestone Toward Market Launch and Strengthening Sisram's Premium Aesthetics Portfolio HONG KONG, Jan. 5, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred...
Admission To Trading on The London Stock Exchange and Completion of Secondary Listing
PARIS, NEW YORK, and LONDON, Dec. 10, 2025 /PRNewswire/ -- The Generation Essentials Group ("TGE" or the "Company", NYSE and LSE: TGE) refers to its announcement published on December 5, 2025 relating to the approval by the UK Financial Conduct...
Innovent Announces Completion of First Participant Dosed in the Seventh Phase 3 Clinical Trial (GLORY-OSA) of Mazdutide in China
SAN FRANCISCO and SUZHOU, China, June 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...